(Report ID: 141034) Drug interactions analysis of:
Megace Es, Nexium, Felodipine, Lisinopril, Allopurinol, Synthroid, Folic Acid, Vitamin B-12, Norvasc, Pyridoxine HclMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,580 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 3 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 141034 | May, 1, 2006 | 78 | Male |
List of drugs the patient takes:
| Drug |
Megace Es |
Nexium |
Felodipine |
Lisinopril |
Allopurinol |
Synthroid |
Folic Acid |
Vitamin B-12 |
Norvasc |
Pyridoxine Hcl |
| Name |
Deep Vein Thrombosis |
Pneumonia |
Pulmonary Embolism |
Results from eHealthMe: 3 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Deep Vein Thrombosis | 1 (33.33%) |
Pneumonia | 1 (33.33%) |
Pulmonary Embolism | 1 (33.33%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Pain | 1 (100.00%) |
2 | Oedema Peripheral | 1 (100.00%) |
3 | Accidental Exposure | 1 (100.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Sucralfate | 1 |
2 | Vitamin Cap | 1 |
3 | Methotrexate | 1 |
4 | Zolpidem Tartrate | 1 |
5 | Clonazepam | 1 |
6 | Humira | 1 |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Oedema Peripheral | 1 (33.33%) |
2 | Pain | 1 (33.33%) |
3 | Accidental Exposure | 1 (33.33%) |
4 | Ejaculation Disorder Nos | 1 (33.33%) |
5 | Pneumonia | 1 (33.33%) |
6 | Pulmonary Embolism | 1 (33.33%) |
7 | Deep Vein Thrombosis | 1 (33.33%) |
| Name | Count |
1 | Clonazepam | 1 |
2 | Humira | 1 |
3 | Zolpidem Tartrate | 1 |
4 | Methotrexate | 1 |
5 | Vitamin Cap | 1 |
6 | Sucralfate | 1 |
7 | Tenormin | 1 |
8 | Mirapex | 1 |
9 | Relafen | 1 |
10 | Slow-k | 1 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
